The company states: “Select Medical (SEM) has received a non-binding indication of interest from Robert A. Ortenzio, Executive Chairman, Co-Founder and Director of Select Medical, to acquire all of the outstanding shares of Select Medical for cash consideration of $16.00 to $16.20 per share of our common stock. Mr. Ortenzio publicly announced the Proposal on November 24, 2025 in a Schedule 13D filing with the U.S. Securities and Exchange Commission. The disinterested members of the Board of Directors of Select Medical are carefully reviewing and evaluating the Proposal in consultation with their advisors and are committed to acting in the best interests of Select Medical and its stockholders.”
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SEM:
- Select Medical’s Earnings Call Highlights Growth Amid Challenges
- Select Medical price target lowered to $17 from $18 at Mizuho
- Select Medical Reports Strong Q3 2025 Financial Results
- Select Medical raises FY25 EPS view to $1.14-$1.24 from $1.09-$1.19
- Select Medical reports Q3 adjusted EPS 23c, consensus 15c